NHI Launches Bioterror Medical Alert, a Twice-monthly Source of News and Guidance for Doctors and Other Healthcare Professionals Business Wire
click here to return to Business Wire main menu
DonateNow





NHI Launches Bioterror Medical Alert, a Twice-monthly Source of News and Guidance for Doctors and Other Healthcare Professionals

Business Wire - November 7, 2001


ATLANTA--(BW HealthWire)--Nov. 7, 2001--Atlanta-based National Health Information, LLC, one of the country's leading healthcare publishers, today announced the launch of Bioterror Medical Alert, a twice-monthly newsletter providing doctors and other health professionals with up-to-the-minute news and guidance on the clinical and public health challenges associated with the growing - and now very real - threat of bioterror.

According to NHI President David Schwartz, the new publication is in response to an urgent need for information being expressed by doctors and other healthcare workers in the wake of the recent anthrax attacks and the increasing likelihood of other bioterror attacks in the future.

"In the midst of these unfolding events it has become clear that our medical system is simply unprepared to deal with the myriad clinical and public health issues raised by the rapid introduction of illnesses that, up to now, most physicians and health facilities have simply never diagnosed and treated," Schwartz said in announcing the new publication. "In response to this crisis - and because of the huge gaps in knowledge and information that become more apparent as each day passes - National Health Information has mobilized its journalistic forces to provide healthcare professionals with the most up-to-date news and reliable guidance available on the medical and public health issues raised by the threat of bioterrorism."

Bioterror Medical Alert is specifically targeted to the clinical concerns of physicians, public health professionals, and other healthcare providers, focusing on diagnosis, treatment, prevention, safety, and disaster preparedness. It will cover not only the current anthrax attacks, but also the many other bioterror threats that physicians and other health professionals must now prepare for, including smallpox, botulism, plague, and dozens of other agents that public health officials are now warning could be next in the terrorist arsenal.

Topics to be covered include:

-- Flu versus anthrax - diagnostic markers

-- Handling "anthrax anxiety" syndrome

-- Smallpox scenarios and medical preparedness

-- Vaccines - pros and cons of widespread vaccination

-- Cipro versus doxycycline

-- Combination therapies for anthrax on the horizon

-- Hospital and office safety practices with anthrax-exposed patients

-- Preparing for smallpox quarantines

-- Food poisoning or bioterror - when to be suspicious

-- Prevention for public safety workers

-- Disaster planning and worst-case scenarios

-- Making a definitive anthrax diagnosis

-- Cipro overuse - public health implications

-- Medical review of smallpox, botulism, plague treatments

-- Hospital infection control in the wake of bioterror attacks

-- Keeping lab workers safe

-- Cutaneous anthrax - how to spot it

-- Keeping up with the CDC's investigators

-- Anthrax transmission - how many spores does it take?

-- How vulnerable are hospitals to attack?

NHI is making the publication available on a free trial basis. The four-issue trial can be requested by calling 800-597-6300, e-mailing a request along with a full physical mailing address to nhi@nhionline.net, or go to www.nhionline.net/products/bma.htm.

CONTACT: NHI Publicatons, Atlanta David Schwartz, 404/607-9500

SOURCE: NHI Publications


011107
BW011107


Copyright © 2001 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .